{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:39:23Z","timestamp":1791398363681,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.maturitas.2008.11.011","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T10:36:11Z","timestamp":1229423771000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Reprint of Pharmacological profile of progestins"],"prefix":"10.1016","volume":"61","author":[{"given":"Regine","family":"Sitruk-Ware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2008.11.011_bib1","unstructured":"Henzl MR, Edwards JA. Pharmacology of progestins: 17\u03b1- hydroxyprogesterone derivatives and progestins of the first and second generation. In: Sitruk-Ware R, Mishell Jr DR, editors. Progestins and antiprogestins in clinical practice. New York: Marcel Dekker; 2000. p. 101\u201332."},{"key":"10.1016\/j.maturitas.2008.11.011_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200201000-00003","article-title":"Progestogens in HRT: new molecules","volume":"9","author":"Sitruk-Ware","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.11.011_bib3","unstructured":"Oettel M, Holz C. Hybrid progestins: the example of dienogest. In: Sitruk-Ware R, Mishell Jr DR, editors. Progestins and anti-progestins in clinical practice. New York: Marcel Dekker, 2000. p. 163\u201378."},{"key":"10.1016\/j.maturitas.2008.11.011_bib4","first-page":"1816","article-title":"Effects of the new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the reninaldosterone system, body weight, blood pressure, glucose tolerance and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.11.011_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0039-128X(99)00109-9","article-title":"Synthesis and biological activity of a new progestogen, 16-methylene-17a-hydroxy-18-methyl-10-norpregn- 4ene-3","volume":"65","author":"Tuba","year":"2000","journal-title":"20-dione acetate. Steroids"},{"key":"10.1016\/j.maturitas.2008.11.011_bib6","first-page":"710","article-title":"The pharmacological profile of TX 066 (17a-acetoxy-6methyl-19- nor-4, 6-pregna-diene-3, 20-dione) a new oral progestative","volume":"33","author":"Paris","year":"1983","journal-title":"Drug Res"},{"key":"10.1016\/j.maturitas.2008.11.011_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone\u00ae: a progestin with a unique pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.maturitas.2008.11.011_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/09513599909167574","article-title":"The pharmacological profile of a novel norpregnane progestin (trimegestone)","volume":"13","author":"Philibert","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2008.11.011_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1749-6632.1977.tb29427.x","article-title":"Androgenic, synadrogenic and anti-androgenic actions of progestins","volume":"286","author":"Bullock","year":"1977","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.maturitas.2008.11.011_bib10","first-page":"70","article-title":"Anti-androgenic properties of nomegestrol acetate","volume":"45","author":"Duc","year":"1995","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"10.1016\/j.maturitas.2008.11.011_bib11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1210\/jcem-42-5-912","article-title":"The effect of medroxyprogesterone acetate on the pituitary-adrenal axis","volume":"42","author":"Hellman","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.11.011_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestogens","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.maturitas.2008.11.011_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0010-7824(81)90018-4","article-title":"Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys","volume":"24","author":"Dusterberg","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.11.011_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and anti-androgenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.11.011_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-73-4-837","article-title":"Dihydrospirorenone (ZK30595), a new progestogen with anti-mineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin\u2013aldosterone system in normal women","volume":"73","author":"Pollow","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.11.011_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0960-0760(93)90105-6","article-title":"Enzyme immunoassay for nomegestrol acetate in human plasma","volume":"46","author":"Ezan","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.11.011_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0010-7824(93)90117-P","article-title":"Pharmacokinetics and bioavilability of ST1435 administered by different routes","volume":"48","author":"No\u00e9","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.11.011_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-73-4-837","article-title":"Dihydrospirenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the rennin\u2013aldosterone system in normal women","volume":"73","author":"Oelkers","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.11.011_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2008.11.011_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2008.11.011_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00310-9","article-title":"Effect of dienogest-containing oral contraceptives on lipid metabolism","volume":"65","author":"Wiegratz","year":"2002","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.maturitas.2008.11.011_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00003495-199856050-00007","article-title":"I M. Dienogest","volume":"56","author":"Foster","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.maturitas.2008.11.011_bib23","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/0735-1097(94)90184-8","article-title":"Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys","volume":"24","author":"Williams","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2008.11.011_bib24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0002-9378(98)70149-8","article-title":"Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in non human primates","volume":"179","author":"Williams","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.11.011_bib25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.10.6.1051","article-title":"Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone","volume":"10","author":"Adams","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.maturitas.2008.11.011_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of factor V leaden mutation","volume":"87","author":"Kemmeren","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.maturitas.2008.11.011_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case\u2013control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.11.011_bib28","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.maturitas.2008.11.011_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.11.011_bib30","doi-asserted-by":"crossref","unstructured":"Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321\u201333.","DOI":"10.1001\/jama.288.3.321"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208003496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208003496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:45:47Z","timestamp":1759913147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512208003496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0378512208003496"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.11.011","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprint of Pharmacological profile of progestins","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}